DF
ABBV icon

DecisionPoint Financial’s AbbVie ABBV Stock Holding History

DecisionPoint Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26K Sell
13
-19
-59% -$4.09K ﹤0.01% 271
2026
Q1 		$6.96K Sell
32
-16
-33% -$3.55K ﹤0.01% 203
2025
Q4 		$11K Buy
48
+16
+50% +$3.65K ﹤0.01% 190
2025
Q3 		$7.82K Hold
32
– – ﹤0.01% 152
2025
Q2 		$6.08K Buy
+32
New +$5.95K ﹤0.01% 168
2023
Q4 		– Sell
-35
Closed -$5.22K – 211
2023
Q3 		$5.22K Hold
35
– – ﹤0.01% 155
2023
Q2 		$4.72K Hold
35
– – ﹤0.01% 141
2023
Q1 		$5.58K Hold
35
– – ﹤0.01% 130
2022
Q4 		$5.66K Buy
+35
New +$5.37K ﹤0.01% 110

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DecisionPoint Financial's ABBV Position: Q2 2026 in Review

DecisionPoint Financial reduced its AbbVie (ABBV) stake by 59% in Q2 2026, selling an estimated $4.09K and leaving 13 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #271.

DecisionPoint Financial first reported a position in ABBV in Q4 2022 and has held it in 9 quarters since. The position peaked at $11K in Q4 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • DecisionPoint Financial held 13 shares of AbbVie worth $3.26K as of Q2 2026.
  • DecisionPoint Financial sold 19 AbbVie shares in Q2 2026, an estimated $4.09K.
  • AbbVie made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #271 holding.
  • DecisionPoint Financial first reported a position in AbbVie in Q4 2022 and has held it in 9 quarters since.
  • DecisionPoint Financial's AbbVie position peaked at $11K in Q4 2025.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.